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Abstract
The ability to monitor an immune response in the course of vaccination or disease
progression is highly desirable. Currently, no technique is able to generate a compre-
hensive profile of the individual cells involved and the antibodies they produce at a
particular point during the immune response.
The ability to obtain such detailed "snapshots" describing the immune response
with a high level of resolution would have implications for diagnostics and biological
discovery. Improvement in vaccination schemes, specific tailoring of anti-viral admin-
istrations, large-scale monitoring of complex latent infections in a population are all
possibilities that would stem from a better understanding of the dynamics of immune
responses.
Currently available methods for profiling of B cells that produce antigen-specific
antibodies helped clarify humoral responses, but it remains a challenge to generate
measurements capable of detailing the phenotypic changes and secretion patterns of
individual lymphocytes. To address this need a soft lithographic approach termed
microengraving (pEn) - previously used for the isolation and rapid selection of mon-
oclonal antibodies[31] - was further developed and adapted to measure the affinity
and isotype of secreted antibodies.
The objective of this thesis was to employ microengraving in conjunction with
bioinformatics analysis to obtain routinely state-based comprehensive profiles detail-
ing cellular and humoral immune responses to antigens to the level of clonal B cells.
Here I show how bioinformatics methods were employed to generate multidimen-
sional datasets for large numbers of individual primary B cells (102 - 104). These
data include three characteristics of the antibodies secreted by each cell: antigenic
specificity, isotype, and affinity. These data are sufficient to classify individual cells
into distinct groups of related cells using algorithms for data clustering. In a series of
mice immunizations designed to mimic a multipart vaccination, I apply this method
to profile the resulting B cell response with single cell resolution.
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Thesis Supervisor: J. Christopher Love
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Chapter 1
Introduction: Vaccinations &
Immunological Memory
1.1 Vaccination
Infectious diseases and vaccination Infectious diseases are the leading cause of
death in humans worldwide[l]. Only the advent of vaccination and the improvement of
sanitation measures has allowed us to combat effectively the consequences of infection.
Since Jenner and Pasteur established these practices, vaccination has proven to be the
single most effective public health measure to prevent mortality and morbidity from
infections [52]. It is in fact those infectious diseases for which an effective vaccine is
still lacking, such as malaria and HIV/AIDS, that represent the most severe global
health issues and where much of the current research is focused. Contributing to the
success of vaccination worldwide are the relatively low cost, the ease of distribution
and administration and the fact that one administration suffices to give long-lasting
effects, without requiring impractical and tedious maintenance regimens[52, 44, 49].
Basic principle Traditionally, vaccines rely on the exposure of the host to a weak-
ened, less pathogenic form of the antigen. The consequent primary immune response
of the host immune system to the antigen clears the infection and confers long last-
ing protection against susbsequent exposures to the same antigen. This is termed
immunological memory.
1.2 Immunological Memory
Immunological memory is the ability of the immune system to respond more rapidly
and intensely to exposure to a previously encountered antigen. It reflects the exis-
tence of long-lived antigen-specific lymphocytes, which have been clonally expanded
in the course of a primary response. This can be directly shown by adoptive transfer
of memory cells into a naive animal, which is sufficient to transfer immunological
memory to the recipient[22].
Memory cells are generally regarded as a resting population, although it is possible
to observe a small percentage of these cells undergoing division at any one time[36].
IL-7 and IL-15 are amongst the cytokines required for the maintenance of these pop-
ulations [4, 53]. Fundamental to the generation of memory is the involvement of T
cells in the primary immune response. Functional antigen specific B cells secreting
antibodies persist only when accompanied by the primary T helper cell reaction to the
antigen[22]. Once the primary phase of the immune response subsides, the frequency
of B cells diminishes but remains higher than before immunization. These frequencies
of memory B cells are then maintained for the life of an individual, independently
of persisting immunizing agent [35] and are generally reflected in increased antibody
titres against the immunogen[22].
Importantly, only those proteins that elicit the involvement of T cells are capable
of generating significant immunological memory[37]. Memory responses are termed
secondary, tertiary, and so on, depending on the number of repeated exposures to
antigen. Repetitive challenge with an immunogen is called hyperimmunization. Sub-
sequent responses can be distinguished from the primary response in terms of the
frequency and type of antibodies produced, as well as differences in the cell surface
markers of B and T cells involved (for more details see 4.2).
1.3 Following the course of an immunization
Monitoring the course of immunizations requires in principle the tracking of all partic-
ipating mechanisms of immunity. However, humoral immunity and cellular immunity
have been difficult to monitor simultaneously by means of a single technique. Inde-
pendent techniques to measure antibodies titres, specificity, isotype and affinity are
routinely used to monitor humoral immunity and are generally used to evaluate the
level of protective memory induced by previous immunizations. Cellular immunity
can instead be observed by enumerating lymphocytes, whether circulating or resident
in specialized organs like the spleen or the lymph nodes.
1.3.1 Antibodies
For vaccines currently in use the titers of circulating antibodies are usually taken as a
correlate of their level of protection. These titers may be assessed by their neutralizing
capacity, microbicidal activity or simply antigen binding of serum antibodies.
Specific antibodies can be isolated from antiserum by affinity chromatography,
while direct detection and quantification of antigen-specific antibodies are routinely
performed by enzyme-linked immunosorbent assay (ELISA). Briefly, the antigen of
interest is immobilized on a solid support: beads in affinity chromatography and
the surface of adsorbing membranes for ELISA. While the antiserum is in contact
with the solid support, the specific antibodies present in the antiserum bind to the
immobilized antigen. In affinity chromatography, the unbound fraction is washed
away, while the bound fraction is subsequently eluted from the column and collected.
In ELISA, the unbound, non-specific antibodies are washed away in a similar fashion,
but the amount of antibody captured is quantified by means of binding by a secondary
antibody linked to an enzyme. The enzymatic reaction catalyzed by the secondary
antibody provides a direct quantitative measure of the number of antibodies bound
to antigen compared to control.
These technologies, however, are inherently limited in their throughput and the
amount of information that they can provide. For instance, little is known about the
diversity of the antibodies elicited, except in those few cases where relatively large
collections of monoclonal antibodies, produced by hybridomas generated from the
immunized subjects, are available for analysis. The extent to which this approach
biases the estimates of diversity of the B cell repertoire is not known; some B cells may
be more readily immortalized as hybridomas than others. Neither does this approach
reveal the emergence of antibody-based (humoral) immunity over time.
1.3.2 B Cell Frequency
Several methods exist to estimate the frequency of naive and memory B cells that
can bind specific haptens or antigens. These include the Jerne plaque assay[23], the
splenic focus assay[20], a variant of the plaque assay that immobilizes colonies of cells
on discs of filter paper [26], the enzyme-linked immunospot (ELISPOT) assay [13, 14],
and fluorescence-activated cell sorting (FACS)[36].
The Jerne plaque assay or hemolytic plaque assay consists of an hemolytic reac-
tion performed on living splenocytes immobilized in gel. It permits detection and
enumeration of the B cell colonies that secrete antibodies. In the splenic focus assay,
splenocytes are cultured in vitro and B cells secreting specific antibodies are stimu-
lated to proliferate by addition of antigen. Although it is not possible to isolate mon-
oclonal antibodies from single cells, populations of closely-related antibodies can be
isolated and characterized. The filter paper technique improves upon this technique,
allowing one to separate single lymphocyte precursors and stimulate their prolifer-
ation in order to obtain an array of monoclonal colonies ready to be characterized.
Limiting dilution, ELISPOT, FACS all allow the enumeration and isolation of single
antigen specific lymphocytes, which can then be further cultured and characterized.
However, none of these methods give information on the characteristics of the an-
tibodies secreted by the lymphocytes. To date, no single method produces a compre-
hensive and correlated cellular profile that includes, among other traits, the frequency
of antigen-specific B cells present, and multiple characteristics of the antibodies they
produce (specificity, isotype, affinity) with single-cell resolution.
1.4 Cellular Immunity and Current Vaccines
Even though immunological memory involves both long-lasting cellular and humoral
immunity, current vaccines are thought to be successful mostly due to their ability to
elicit a long-lived humoral response [49].
Failure of classic vaccination However, classical vaccination strategies that rely
on eliciting an humoral immune response have increasingly proven insufficient to deal
with emerging infectious disease, where cellular immunity may play a greater role
in host defense. HIV/AIDS represent a striking example of how classic approaches
to vaccine discovery have repeatedly failed. Evolving viral evasion strategies, virus
latency and the integration of viral genetic material into the host genome are some
of the reasons why eliciting humoral immunity is not sufficient to clear or manage
complex infections.
To address this issue, much of the attention in vaccine research is now focused on
eliciting and maintaining specific cellular immunity as well as artificially stimulating
native immunity. However, even though research has increasingly focused on manip-
ulating such cellular immune responses, there remains a shortage of tools to monitor
these responses in detail and at high resolution.
A single technique that could quantitatively describe both humoral and cellular
components of the immune response at the single cell level would substantially help
ongoing research efforts.

Chapter 2
High-throughput measurements of
antibodies affinity
The process underlying the acquisition of immunity after vaccination is very complex
and still remains to be understood in fine detail. The collection of cells of various
types, specificities and activities that constitutes the immune system represents a
fine and intricate network of interactions, regulations and balances, which remain
difficult to explore using current methods. Arguably, the only way these interactions
can be explored systematically is by large scale observations of the behaviour of the
individual players of immunity. Our objective was to enable such observations in a
quantitative fashion. In particular, we wanted to develop a method for the high-
throughput measurement of the amount and quality of secreted antibodies from a
population of lymphocytes. This in turn would allow to a) rapidly identify rare anti-
bodies of particular specificity/affinity and b) obtain a comprehensive picture of an in
vivo antibody repertoire. In order to address this need and enable the measurement
of quantitative parameters in a large collection of individual immune cells, we decided
to employ microfabrication techniques. The ability of manipulating single cells of the
immune system afforded by the fabrication of biocompatible microchips, as well as the
relative ease of use and scalability, has allowed high-throughput sampling of secreted
products and surface markers with unprecedented resolution.
2.1 Soft Lithography
Microfabrication by soft lithography was selected for the purpose of this work. Soft
lithography is a set of techniques for microfabrication based on the use of biocompat-
ible elastomeric materials[55]. Soft lithography relies on printing and molding using
elastomeric stamps with the patterns of interest in bas-relief. Soft lithography offers
the ability to control the molecular structure of surfaces and to pattern the complex
molecules relevant to biology, to fabricate channel structures appropriate for microflu-
idics, and to pattern and manipulate cells. For the relatively large feature sizes used
in biology (> 50/m), production of prototype patterns and structures is convenient,
inexpensive, and rapid.
Generally, microfluidic systems are fabricated with an elastomeric material, poly
(dimethylsiloxane) or PDMS, starting from a micro-patterned silicon wafer employed
as a mold. Briefly, features of the chip (eg. a network of microfluidic channels) are
designed in a CAD program. This design is converted into a transparency by a high-
resolution printer; this transparency is used as a mask in photolithography to create
a master in positive relief photoresist. PDMS cast against the resulting mold yields a
polymeric replica containing all the designed features in bas-relief. The chips are then
oxidized in an oxygen plasma, in order to allow the surface of the chip to seal tightly
and irreversibly when brought into conformal contact. For instance, oxidized PDMS
seals irreversibly to other materials used in microfluidic systems, such as glass or
silicon. Oxidation of the PDMS has the additional advantage that it yields channels
whose walls are negatively charged when in contact with neutral and basic aqueous
solutions, thereby rendering the chip hydrophilic and thus biocompatible.
2.2 Microengraving
Microengraving (pEn) is a soft lithographic technique previously developed in our
laboratory [31] for the rapid selection of monoclonal antibodies from large hybrydoma
populations. It is based on a microfabricated PDMS chip, consisting of an array of
approximately 100000 separated wells, each 50 pm x 50pm x 50pm in size.
Figure 2-1: Microwell chip employed for microengraving. Routinely fabricated in
PDMS by soft lithography, it consists of an array of 50 pm wells
The size of the wells is chosen such that when cells are seeded in the device and
settle in each well by means of gravity, each of the wells contains on average1 a single
cell. Non-specific interactions maintain the cells on the bottom of the wells and ease
the manipulation of the chip loaded with cells. The PDMS chip is then inverted
and placed in firm contact on a glass slide, whose surface is in turn functionalized
with a capture antibody. Each individual cell's secreted products are then captured
on the glass slide by the deposited antibody (or other appropriate moiety), forming
a spatially defined spot. The resulting array of spots, each containing the secreted
products of an individual cell, effectively makes up a protein microarray. Once the
chip is separated by the produced microarray, the process can be repeated multiple
1"Average" here is a misnomer. The process of cells filling the well can be described in terms of
an occupancy problem, a subject of interest in random combinatorics. Depending on the starting
assumptions (eg. uniform cell distribution, low reynolds number, etc.), the distribution can take
many different forms. If the number of cells reaching the chip can be described by a poissondistribution, then the well occupancies become independent Bernoulli random variables and the
overall probability of all wells being occupied by n cells at time t is a binomial random variable withparameters n and exp -t.
times (the current protocol allows up to 6-7 replicates without significant loss of cells
and engraving quality). Each microarray can then be stained with fluorescent moieties
of interest and the resulting fluorescent microarray can then be analyzed by means
of the same instrumentation routinely employed in the analysis of DNA and protein
microarrays. Cells contained in the chip can be easily stained in parallel for relevant
surface markers and the resulting data can be rapidly collected by high-throughput
microscopy. Moreover, cells in the chip remain viable and can be retrieved by custom
automated instruments, allowing further expansion and molecular analysis.
Figure 2-2: Scheme for generating multiple replicates of engraved microarrays of anti-
bodies from a population of cells. After producing microarrays, microwells containing
cells are transferred to media for subsequent enumeration.
2.3 Affinity Measurements
To test the feasibility of the microengraving process for the high-throughput measure-
ments of antibodies affinity, we employed a monoclonal hybridoma line specific for aknown and available antigen. A key feature of pEn is its ability to produce replicate
microarrays of antibodies from a given set of cells with excellent reproducibility. We
measured the affinity of the secreted monoclonal hybridoma by producing microarray
replicates from the secreted antibodies and staining the microarrays with increasing
concentration of the antigen. In principle, by increasing the concentrations of antigen
applied to these replicates, one can define a binding curve (Ag/Ab fractional occu-
pancy vs. concentration) for individual elements in the array, and, in turn, derive the
apparent dissociation constants Kd for the antibodies produced by individual cells
in the array[47]. The precision and consistency of the affinity measurements is then
determined simply by comparing a large number of individual measurements from
the same experiment.
2.3.1 Methods
The microengraving system was employed as described above. Super-Epoxy 2 (Ar-
rayIt SME2) functionalized glass slides were pre-coated with a 1:1 mix of anti-mouse
IgG capture antibody (Southern Biotech 1030-01) and anti IgG (H+L) (Zymed 1010-
01), and then blocked with BSA. These capture antibodies were deposited using
coating buffer (50 mM Borate pH 9, 80 mM Trehalose, 50 mM NaC1).
Approximately 100,000 hybridoma cells specific for ovalbumin (OVA). were then
seeded into one chip. The hybridoma cell line 099-01, secreting anti-OVA was ob-
tained from Statens Serum Institut and maintained in DMEM (Gibco) supplemented
with 10% FBS, 50 units penicillin/50 g streptomycin, 20 mM HEPES, 50 M 2-
mercaptoethanol, 1 mM sodium pyruvate and 0.1 mM nonessential amino acids
(Gibco). Cells were maintained at 5% C02, at 37 C, and split every 2-3 days.
The device was then inverted onto the functionalized glass slide and secreted
antibodies were captured onto the slide during a 30-minute incubation. The process
was repeated 5 times, to obtain 5 replica prints of the same microarray.
Each resulting microarray was exposed to a different concentration of fluorescent
OVA. Because several factors -- including variation in the rates of secretion, and the
efficiency of capture and retention of the antibodies for each replicate print- could
affect the quantity of antigen bound at a given site, we also measured the amount of
antibody present at a given element in the microarray using a fixed concentration of
anti-mouse Ig secondary antibody. As shown in Figure 2-3, non-specific spots (where
the secreted antibodies do not bind OVA) are labelled exclusively by the antibody,
OVA
(var.conc, Green)
. / eanti-mouse Ig
, ) (0lnM, Red)
anti-mouse Ig
Antigen specific spot
4,yY
Non-specific spot
Figure 2-3: Labeling strategy for assessing fractional occupancy of a captured mono-
clonal antibody by antigen at a given element in the microarray. Replicate prints are
exposed to antigen (green) over a range of concentrations (e.g., 10 pM to 100 nM).
while antigen-specific spot show both fluorescent dyes colocalized.
The slides, once probed with fluorescent dye reagents, were scanned by Genepix
4000B and 4200AL microarray scanners, employing the accompanying software Genepix
Pro (Molecular Devices, Sunnyvale, CA) in order to extract features and fluorescent
data. Raw numerical data was then exported to MATLAB (Mathworks, Natick,MA)
for filtering and subsequent statistical analysis.
2.4 Results
2.4.1 Microengraving can be employed to measure fractional
occupancy
Assessing the affinity of an antibody immobilized on a microarray requires measuring
the fractional occupancy of the antibody at several different antigen concentrations
(as in Figure 2-4). In this experiment we employed concentrations ranging from 10
pM to 0.1 AM.
Prints Stamp
I I I
[OVsA
Figure 2-4: Representative composite fluorescent images from five antigen-labeled
microarrays produced by microengraving, and the anti-ovalbumin-specific hybridomas
(stained with CFSE) corresponding to each element in the arrays. Scale bar is 50 m.
The ratio of the median fluorescent intensities of antigen to antibody gave a mea-
sure of the fractional occupancy of the element in the microarray at the applied
concentration of ovalbumin.
2.4.2 Occupancy measurements defined affinity curves with
high accuracy
When the concentration of antibody is kept fixed, while the concentration of ovalbu-
min is increased across a number of replicate microarrays, an affinity curve can be
constructed for each element of the microarray. The resulting data is presented in
Figure 2-5, showing a random sample of approximately 50 microarray spots, each
corresponding to an individual hybridoma clone.
The measured fractional occupancy curves are a direct estimate of the binding
curve of the immobilized antibody. A random sample of 50 clones shows how the
experimental measurements are centered around a median curve, with relatively lit-
C)Q
0
CuM-
X
0.01 0.1 1 10 100
[OVA] (nM)
Figure 2-5: Plot of the fractional occupancies measured for 50 cells (grey lines, se-
lected randomly from the complete dataset of 4,426 single cells) as a function of the
concentration of ligand applied to five replicate microarrays. The average binding
curve fit to these clones (red) and the curve measured by ELISA for the purified
antibody (dashed black line) are shown.
tie variation, demonstrating the consistency of the affinity measurements across the
array. Importantly, no normalization was necessary here to compare these individual
independent elements. It is important to notice how the estimate of affinity here
is not biased by effect of bivalent binding as it could be with surface immobilized
ELISA, since the antibody fraction here is bound, while the antigen is in solution.
This leads to more precise estimate of binding pocket affinity, rather than effective
avidity of the antibody.
2.4.3 Conclusions
Microengraving, with the ability of analyzing secreted products of individual cells in
a highly parallel fashion, allows the high-throughput quantitation of secretion levels
and characterization of secreted products. By exploiting the ability to replicate the
protein microarrays with high fidelity, we have shown how precise measurements of
antibodies affinity can be routinely performed over a large number of monoclonal cells.
This can in turn allows the screening of desirable high-binding clones in a population
of antibody-producing cells or, as further explored in this thesis, the compilation of
affinity "maps" detailing the repertoire responsible for the humoral immune responses.

Chapter 3
Resolving clonal B cell populations
by measuring affinity of secreted
antibodies
The consistency of the binding curves produced by each OVA-specific hybridoma
in the experiment described above, suggested the potential of identifying individual
clones within a mixed population of cells by their relative affinities.
To test the feasibility of this approach we attempted to distinguish a limited
and known number of hybridoma lines secreting antibodies for a common antigen.
By measuring affinity curves in a high-throughput fashion, we aimed to determine
whether the measurements were sensitive enough to allow discrimination between
subtly different antibody producing cells.
3.1 Experimental methods
We repeated the experiment described in 2.3 with a mixed population of three differ-
ent hybridomas. We choose three hybridoma cell lines specific for the same antigen
(H2Kb), albeit with varying affinity.
The Y3 cell line, secreting anti-H2Kb antibody was a kind gift of Dr. P Cresswell.
Anti-Kb hybridoma lines (JCL127 and JCL136) were described recently. All hybrido-
mas were maintained in DMEM (Gibco) supplemented with 10% FBS, 50 units peni-
cillin/50 pg streptomycin, 20 mM HEPES, 50 ipM 2-mercaptoethanol, 1 mM sodium
pyruvate and 0.1 mM nonessential amino acids (Gibco). Cells were maintained at 5%
C02, at 37 C, and split every 2-3 days.
The three populations were differentially labelled with cytosolic dyes (c136 with
CellTracker Blue CMAC, c127 with CellTracker Red CMTPX, Y3 with CFSE), so
that information on their original identity was retained, and then deposited into the
microwell chip (as above, 100000 wells each 50 x 50 x 50 pm 3).
Seven replicate microarrays were generated by [pEn, and probed with anti-mouse
IgG (red) and tetrameric Kb-streptavidin (green). Each hybridoma was labeled with
a unique cytosolic dye prior to their deposition in microwells, and after the final print,
all of the cells were stained in situ for DNA.
The intracellular stains did not interfere with antibody secretion or cellular viabil-
ity, and allowed us to correlate the identity of each cell with their measured binding
curves.
The experiment yielded a model set of data comprising some 3700 cells. A
representative random sampling of these curves is shown in Figure 3-1.
Even when looking at a single block in the microarray, it is already possible to
observe how three very distinguishable curves are observable. This visual classification
is rapidly verified by coloring the curves based on the information extracted from the
cytosolic dyes.
The quantification of the antigen/antibody ratio was here done manually for every
clone, an approach that quickly limited the throughput of our analysis. To increase the
yield of each experiment and to allow routine quantitative observations, we expanded
and automated the data mining process.
3.2 Data Mining
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Figure 3-1: A plot showing the fractional occupancy, as a function of the concen-
tration of tetrameric H-2Kb, measured for a set of cells. The colors of the traces
correspond with the verified identity of the clone (Y3, aqua; c127, magenta; c136,
purple). Representative images of one microarray and the corresponding composite
fluorescent image of the cells are also shown.
Imaging Arrays of microwells were placed face down with a thin layer of PBS onto
the surface of a glass slide, and imaged on an inverted epifluorescence microscope
(Nikon Eclipse TE2000-E) equipped with a Hamamatsu Orca AG camera and an au-
tomated x-y translation stage (Prior Instruments). Overlapping images were acquired
for the entire array using the ScanSlide module in the Metamorph software package
(v7.1, MDS). Images of complete blocks of microwells (40 x 40 wells x 52 blocks per
device) were assembled using the Scan Slide module in Metamorph for each data
channel acquired, as exemplified by 3-2.
Grid alignment & data extraction Fluorescence intensities, signal-to-noise ra-
tio, and other various parameters were extracted from the microarray scans by means
of the commercial software Genepix. Due to the slight deformability of PDMS and
the poor tolerance built into this software, grids had to be aligned manually. We ex-
pect this process to be exponentially reduced by the development of custom software
(see below)
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Figure 3-2: Representative fluorescent image of a 40 x 40 microwell block
In order to extract the required data from each of the acquired blocks and correlate
it with data from the microarray scans, it was necessary to preserve the given spatial
information. Grid alignment was performed semi-automatically in metamorph to
produce working images such as the one depicted in Figure 3-3
Once the grids were aligned, semi-automated tabulation of the number of cells
found in each well, and their expressed surface markers, was also generated using
custom macros written in Metamorph (available upon request).
As an alternative to this tedious process, automated algorithms are under active
development. In collaboration with Bjorn Nilson (Broad Institute), we are developing
custom code able to perform completely automated alignment. The sophisticated
algorithm can be described briefly:
1. binarize the image
2. projection of the information-containing pixels of the transmission image onto
the cartesian axis of the image.
3. rotation of the image consistent with the distribution of the projected intensities
4. elastical stretching of a pre-defined grid to match the distribution of the pixel
axis
Figure 3-3: Grid alignment in Metamorph software
5. transfer of the fitted grid to all previously segmented fluorescent images, asso-
ciated with the same element of the microarray
6. quantitation of parameters
Data Correlation Filtered information from a) affinity slides and b) cellular stains
(imaged by epifluorescence microscopy) was correlated on the basis of relative spatial
coordinates. Raw data collected by a) Metamorph analysis of the PDMS chip images
and b) microarray scans was imported into MATLAB (Mathworks, NA) for further
processing. The data is represented as closed struct data structures in matlab,
with shared array coordinate systems. Initial selection of the features and successive
aggregation of the dataset in a more manageable form (ie. multidimensional array)
was done by means of routine data manipulation scripts. Selected parameters for
further analysis were a) 568/635 fluorescent ratios for antibody microarray data and
b) boolean variable classifying each cell in the chip as positive or negative for any
given marker.
Filtering, however, had to be performed to restrict the size of the dataset prior to
these processing steps.
Filtering
Wells that contained more or fewer than 1 cell - as determined by counting the
number of nuclei in the DAPI fluorescent channel - were excluded from subsequent
analysis. Similarly, cells that failed to show any staining in any of the three channels
corresponding to cytosolic dyes were also excluded.
Scanned spots with poor signal quality (high spot covariance, low signal to noise
ratio and/or high saturation levels) were filtered from the dataset. Good quality spots
were then ranked as Ig+, by setting a threshold on the background corrected median
intensity, total intensity and signal to noise ratio in the corresponding channel. A
detailed MATLAB script, outlining the algorithm for flagging good quality spots is
contained in the Appendix (see A).
3.3 Data Clustering
The filtered dataset which is mined from a single microengraving experiment is exten-
sive and multidimensional in nature. Interestingly, it resembles in its characteristic
the data routinely collected by oligonucleotide microarrays: gene expression signa-
tures are replaced here by affinity curves corresponding of the secreted antibody.
Likewise, approaches employed in gene expression arrays to identify relevant patterns
in the dataset are also similar. In particular, this thesis is concerned with the use
of unsupervised clustering methods to the detection and monitoring of biologically
significant population in an unknown sample.
3.3.1 Clustering Methods
Current clustering algorithms can be subdivided into two major categories: a) super-
vised methods, which rely on some a priori knowledge of the expected pattern and
b) unsupervised methods, which attempt to identify significant clusters without prior
knowledge regarding the expected data [7].
Although unsupervised methods such as nearest-neighbour analysis, neural net-
works or support vector machines could undoubtedly be applied to the data collected
by microengraving, they require a larger number of experiments to be performed be-
fore any substantial knowledge regarding the characteristic of the dataset is obtained.
The proof-of-principle analysis presented in this thesis is therefore based on unsuper-
vised methods, such as nearest-neighbor clustering, self-organizing maps, hierarchical
clustering and k-means clustering. These clustering methods build on an array of
dissimilarity measures to create groups of features with similar patterns[7].
Principle Each pattern, be it a gene expression pattern or an affinity pattern, is de-
scribed by a point in a multidimensional space, where each dimension corresponds to
an experiment or, in this case, to a different antigen concentration. The coordinates of
the point are determined by the relative measurements of the same well at the various
antigen concentrations. The similarity between patterns is judged quantitatively by a
distance measurement over this multidimensional space. Various alternative distance
metrics exist and is good norm to use multiple ones while clustering the same dataset,
to pick out potential biases due to the metric employed[40].
Hierarchical Clustering Closely related patterns are joined together to form a
new combined leaf by a linkage method. Many choices exist here as well and should
be routinely explored for any given experiment.
In hierarchical clustering, the linking process is repeated iteratively until all nodes
are connected, resulting in a hierarchical relationship structure. Dendrograms are
generally used to represent the resultant hierarchical tree, showing branches between
interrelated patterns and thus visually highlighting dominant clusters. The quality of
the description is usually judged by calculating the cophenetic distances and the cor-
responding cophenetic correlation coefficient. The cophenetic correlation coefficient
is a measure of how faithfully a dendrogram preserves the pairwise distances between
the original unmodeled data points. Higher cophenetic coefficients correspond to bet-
ter quality descriptions and are used to select the best distance/linkage combination
for the given dataset.
K-means clustering K-means clustering falls into the category of unsupervised
partitioning methods, where the number of cluster is determined a priori. The dataset
is split consequently, in order to maximize the distinction between the given number of
clusters. It has the disadvantage of requiring some knowledge of the dataset, although
in general K-means clustering is repeated varying the number of desired clusters and
comparing the clustering results, in order to identify the cluster number that has
produced the highest quality separation (and thus more likely resembles the number
of clusters effectively present in the given dataset)
Principal Component Analysys The quality of the linkage method and the fea-
ture of the dataset can be visually explored by means of principal component analysis
(PCA). This mathematical technique allows one to find the linear combination of the
multidimensional dimensions that would explain most of the variation in the dataset.
Effectively, this allows a remapping of the multidimensional space in which every
affinity pattern lies in a more treatable two- or three-dimensional space. By making
possible the actual visualization of the dataset, PCA allows to identify relevant fea-
tures in the data and, potentially, detect significant clusters from the measurements
taken.
3.4 Results
Microengraving analysis of the antibodies secreted by a population of three mixed
hybridoma populations lead to a total of 5,000 individual cells with a complete dataset
associated with it. Attention was restricted to the best quality dataset, consisting of
approximately 3,600 single cells.
3.4.1 Clustering of the mixed hybridoma dataset
Unsupervised clustering, either by hierarchical or partitioning methods, was per-
formed in MATLAB to resolve distinct biologically meaningful classes of clones.
Cophenet distances and coefficients were computed to assess the quality of differ-
ent hierarchical methods. Only hierarchical clustering methods yielding an average
cophenetic correlation coefficient > 90% were employed. Silhouette and gap statistics
were similarly employed to identify the adequate number of clusters in partitioning
methods (ie. k-means). Principal component analysis (PCA) was routinely used to
monitor the distribution of the selected dataset and to examine the quality of the
clustering results.
3.4.2 Heatmap visualization of affinity measurements
To evaluate the results of clustering algorithms and allow rapid visual inspection of
the dataset, it was necessary to develop a novel representation system. The ensemble
of affinity measurements can be represented as a series of independent curves, but
it rapidly becomes confusing to distinguish individual curves when their number is
greater than 50. An alternate way of displaying these curves is to center each curve
such that the median value is set at zero, and map the data as a density plot where
points above and below the median are shown in contrasting colors, as shown in
Figure 3-4.
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Figure 3-4: Effect of the median centering of each affinity curve on the color mapping
scheme employed. High affinity binders show brighter red and blue bands. Non
saturated antibodies (KD > 100nM) show only blue coloring. Low affinity antibodies
are deprived of any coloring.
Depicted in this manner, visual inspection permits an estimate of two charac-
teristics of the antibodies: the white region indicates the median value, and thus it
approximates Kd within an order of magnitude, while the intensities and progression
of the colored regions indicates the strength of the binding interaction and suggests
whether the antibody is fully saturated or not in the range of concentrations analyzed.
3.4.3 Affinity curves were sufficient to distinguish clonality
of antibodies producing cells
Unsupervised clustering of the individual binding curves allowed a clear distinction
of the different clones within the dataset, as shown here in Figure 3-5. Both unsu-
pervised, hierarchical and partitional (k-means) clustering algorithms showed a high
degree of accuracy when sorting cells into groups of identical clones (see Table 3.1).
We used the identities of the cells determined by immunofluorescence as a reference
to assess the accuracy of the assignments made by clustering. Principal component
analysis (PCA) of the dataset also yielded three dominant clusters, evident by vi-
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Figure 3-5: Hierarchical (city/ward) and k-means (n=3) cluster analysis of the binding
profiles measured for the three clones (3,711 cells). Median profiles for each group in
the k-means clusters are superimposed.
sual inspection of Figure 3-6. All three analyses resolved the difference in measured
avidities between two clones, Y3 (0.60 nM) and c136 (3.77 nM).
3.4.4 Clustering based on affinity-resolved populations with
high sensitivity and specificity
We estimated the sensitivity of the affinity clustering method by comparing it with
the data obtained by immunofluorescence of the same cells (and thus the known
cell identity). For instance, true positives were those cells that were classified by
unsupervised method as being of the cell type previously determined by cytosolic
stain. The average sensitivity (ratio of true positives to combined true positives and
false) was greater than 87% for both methods, and the average specificity (ratio of
true negatives to combined true negative and false positive) was greater than 94% as
detailed in Table 3.1, together with estimates of the positive and negative predictive
value of the test.
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Figure 3-6: Principal-components analysis of binding profiles. Single cells are plotted
as a function of the first two principal components. Colors indicate the identity of the
cells when determined (A) by intracellular staining and (B) by hierarchical clustering.
The vectors show the two-dimensional projection of the original multidimensional
basis of the principal-component space.
Table 3.1: Sensitivity and specificity of clustering algorithms to hybridoma data
Classifier Y3 c136 c127 Avg.
Sensitiv-
ity
Avg.
Speci-
ficity
Avg.
PPV
Avg.
NPP
0.6
0.4
0.2
0
-0.2
-0.4
-0.6
-0.8
-1
-1.2
Cellmarkers 1527 856 1328 - -
K-means 1482 831 1398 87.0% 94.3% 87.0% 94.4%
Hierarchical 1617 744 1350 88.3% 95.2% 89.8% 95.6%
3.4.5 Conclusions
This work demonstrates the ability of distinguishing antibody-secreting cells on the
basis of the affinity curve of their secreted antibody. Perhaps surprisingly, the cor-
relation between affinity of the secreted antibody and identity of the secreting cell
is a robust one. Therefore, antibodies affinity curves could potentially be employed
as "signatures" of the antibodies-producing cells, in a manner analogous to the use
of gene expression signatures as univocal identifiers of genes in oligonucleotides mi-
croarrays.
Along the same lines, analysis of microengraving data may lead to phenotypic
studies of cellular populations (eg. the immune system) resembling in character the
molecular studies that microarray technology has enabled thus far.
In particular, the ability to profile the cellular and humoral immune system at any
given state may open up many opportunities for biological discovery and diagnostic
applications.

Chapter 4
Multivariate Profiling of Immune
Responses during the Course of a
Vaccination
Having shown the ability of distinguishing immunoglobulin produced by antibody-
secreting cells of similar specificities by their antigen binding curves, it should be
possible to analyze the diversity among a more heterogeneous population of primary
B cells. The ability to map in vivo B cell responses is of particular interest in the
field of vaccinology and, thus we decided to test the feasibility of the microengraving
approach in describing and monitoring a classic immunization.
The objective of the experiments was to test our ability to determine frequencies
of antigen-specific cells, while at the same time measuring the affinity and isotype
of secreted antibodies. Manipulation and correlation of these data by bioinformatics
methods would in turn demonstrate the ability to compile profiles or "snapshots" of
the in vivo humoral immune response to a protein antigen. Moreover, the ability to
gather an highly multidimensional dataset might permit the detection of biologically
significant groups of interrelated immune cells.
4.1 Immunizations
Immunization schemes vary considerably depending on i) the nature of the antigen,
ii) its immunogenic potential (measured as the capacity to elicit protective level of
circulating antibodies following exposure), iii) the dose, iv) the adjuvant employed
and v) the delivery route.
The immunogen employed can either be an a) inactivated pathogen, b) an atten-
uated organism with reduced pathogenicity (eg. by passing the virus in cell cultures),
c) a conserved protein component found in the pathogen, d) pathogens which have
been genetically engineered to reduce mutations and potential for infection or e) pep-
tides. Antigens can also be used in conjugated form (eg. to carrier proteins) in order
to elicit more than one mechanism of immunity. Adjuvants, such as inorganic salts
or emulsions containing killed bacteria, are routinely used to enhance the immuno-
genicity of antigens.
The immunogenic potential of an antigen can depend on a variety of factors.
Larger, complex aggregated proteins are generally more immunogenic than soluble
small molecules. Similarly, antigens that largely differ from self proteins and are well
processed in the MHC pathway tend to have increased immunogenicity.
Doses of antigen employed in immunization should not be too high or too low. If
the dose of immunogen administered in a primary immunization is too low, little or
no immune response can be detected. If the dose is too high, on the other hand, the
immune system can develop tolerance to the antigen, failing to develop immunological
memory. Doses employed in subsequent immunization are usually progressively lower,
since the presence of memory is responsible for immune responses at lower antigen
doses.
The use of adjuvant is generally required to elicit sufficient immune responses and
to favour the involvement of multiple mechanisms of immunity. Adjuvants enhance
the immunogenicity of an antigen by a) converting soluble proteins into particulate
material and b) by means of their microbial components, which are capable of stimu-
lating the production of cytokines, induce inflammatory responses and activate TLR
receptors pathways.
Routes of immunogen administration change the rapidity by which the antigen
is released and in turn is recognized by the cells of the immune system. In general,
slower release favors immunogenicity, with the subcutaneous route being the most
immunogenic, followed by intraperitoneal and intravenous.
Lastly, immunization schemes employed in human vaccinations are also affected by
collateral considerations such as age, the potential infectivity and the risk of exposure
for the particular individual.
4.2 Adaptive Immune Responses following Immu-
nizations
Primary exposure to antigen and complete adjuvant triggers a primary immune re-
sponse, which is characterized by the the production of specific antibodies and specific
effector T cells. The intensity of the response, as measured by the production of an-
tibodies, peaks around 6-7 days following injection and then slowly decreases but
does not return to base level. Detectable levels of specific antibodies remain in the
circulation as one of the signs of acquired immunological memory.
Subsequent responses can be distinguished from the primary response in terms
of the frequency and type of antibodies produced, as well as differences in the cell
surface markers of B and T cells involved.
The natural course of a B cell response to an antigen involves an initial burst of IgM
production. Upon secondary stimulation, or if antigen persists and a suitable source of
T cell help is available, antigen-specific B cells undergo antigen-driven proliferation
(frequency of antigen-specific B cells in immunized animals can be up to 100 fold
higher than in immunized animals), somatic hypermutation (with consequent affinity
maturation of the secreted antibodies) and isotype switching (resulting in increasing
levels of IgG antibodies being produced versus less mature IgM antibodies).
4.3 Collecting snapshots of the humoral immune
responses
To test the feasibility of affinity-based profiling in monitoring an in-vivo immune re-
sponse, we analyzed the antibody secretion of stimulated splenocytes harvested by
mice undergoing an immunization series. The objective of this work was to determine
whether microengraving would allow the description of known processes occurring
during immunizations, such as antigen-specific B cell proliferation, affinity matura-
tion and isotype switching. Furthermore, this work was directed to the application
of clustering techniques for the detection of relevant B cell population previously
unobserved.
Enhancements in the microengraving process allow to profile primary cells
Further refinements of the microengraving technique allowed us to analyze the secre-
tory pattern of primary B cells, which are generally smaller (and thus more difficult to
image), require stricter culture conditions and secrete less antibodies than hybrydoma
lines. Specifically,
* Improvements in the signal to noise ratio:
- Buffer optimization for the functionalization of glass slides with capture
antibody
- Optimization of the capture antibody mix used for slides functionalization
- Optimization of engraving time vs. number of microarray replicates
* Faster and more accurate image analysis and data mining, by means of opti-
mized scripts
* Choice of minimal cell separation methods prior to cell seeding in the PDMS
device.
* Non-specific stimulation by lypopolysaccharide (LPS) to boost antibody secre-
tion levels
Hyperimmunization Hybrid strain mice (between 129 and Balb/c) were immu-
nized with a mixture of OVA (50 ug) and HEL (50 Mg) in a CFA emulsion, and
boosted at day 14, and day 27 with IFA antigen emulsion. Splenocytes (1 x 106 in
RPMI 1640) were harvested from unimmunized mice, as well as immunized mice 18
days after the initial immunization, and stimulated with Lipopolysaccharide (LPS;
20 g/ml) for three days, and seeded into grids for microengraving analysis on day
21. On day 31, splenocytes from a second mouse, subjected to 1st and 2nd booster
immunizations on day 14 and 27 respectively, were similarly collected and analyzed
on day 34 after the primary immunization (see Figure 4-3).
To classify individual B cells, the three parameters we considered were specificity,
affinity, and isotype. Specificity and isotype can be readily scored by application of
a single reagent: a fluorescently labeled antigen (specificity) or an appropriate sec-
ondary antibody (isotype) to microarrays of captured antibodies produced by MtEn[31].
Six replicate microarrays were generated by pEn. One replicate was stained with anti
IgM (Alexa 594), anti IgGI (Alexa 647), anti IgG2a (Alexa 532) and anti IgG2b
(Alexa 488) antibodies to distinguish the isotype of the secreted antibodies. Five
replicates were probed with anti-mouse Ig(H+L) (Alexa 647, red) and increasing con-
centrations of ovalbumin-Alexa 555 (green). After engraving, the cells were fixed with
4% paraformaldehyde, labeled with a nuclear stain (Hoescht 33342, 1 g/ml) and two
primary antibodies (anti-IgM-Alexa 647 and anti-B220-rhodamine), and imaged for
enumeration.
Multiparametric profiling of individual cells:surface markers and secreted
antibodies Information obtained from data mining included 1) phenotypic surface-
expressed markers for identifying individual B cells (IgM and B220), 2) the isotype
of the antibody produced by a cell (IgM, IgG1, IgG2a, IgG2b), and 3) the binding
curve of that antibody for ovalbumin.
The resulting multidimensional dataset was correlated on the basis of relative
spatial coordinates. Once the full multidimensional dataset was assembled, a subset
of wells was selected for further analysis.
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Figure 4-1: A representative set of raw data for a single splenocyte.
Filtering of the multidimensional dataset While some of the non-secreting B
cells may be specific for ovalbumin, we had to limit our analysis to those cells induced
to secrete antibodies. We further limited our dataset to those cells for which a com-
plete binding curve was also available. All such datasets included five distinct and
high quality replicates of the antibody taken from all microarrays interrogated with
ovalbumin. The uniformity and signal-to-noise ratios for a given element on one or
more replicates were factors that excluded some cells; both technical and biological
variability contributed to the exclusions. While these stringent quality conditions fur-
ther reduced the datasets, there remained at least 645 individual antibody-secreting
B cells to analyze for each mouse.
4.4 Results
4.4.1 Antibodies with detectable affinities revealed antigen-
specific B cells
Antigen specific clones in the mouse dataset were identified fitting a langmuir binding
isotherm by non linear least squares ( 95% confidence interval) to every affinity curve
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Figure 4-2: Heatmaps for binding curves measured for Ig+ cells with good quality
data from immunized mice. The cells are sorted by dissociation constant. A threshold
is set to distinguish a subset of "antigen-specific" clones.
A threshold was determined following visual inspection of the data, allowing to
separate clones with measurable Kd (<100 pM) from low binders and non-specific
clones.
4.4.2 Isotype information defined the antibody secreting pop-
ulation
We took the isotype slide as the reference measure of the Ig secreting cells in a given
grid. Scans of isotype slides were consistently of better quality (ie. higher signal to
noise ratio, higher number of positive spots) then the scans obtained for the affinity
slides. This can be accounted for by the fact that isotype staining was performed on
the first print obtained by the grid (with the fewest number of dislodged cells) and
four separate anti Ig antibody were employed.
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4.4.3 Microengraving detected an increase in the fraction of
antigen-specific B cells
B cells (B220+ and/or IgM+) comprised the major fraction of single cells deposited in
microwells after stimulation with LPS. Some 20-30% of those cells, however, actively
secreted antibodies that corresponded to one of the four isotypes scored (IgM, IgG1,
IgG2a, or IgG2b). For splenocytes from immunized mice that received no stimulation
ex vivo, the percentage of immunoglobulin secreting cells was 0.1 1%. Immunization
followed by a booster injection yielded an increase in the percentage of antigen-specific
B cells.
* = immunization I = sacrifice m = cells in culture/LPS
0 5 10 15 20 25 30 35
1 days
2x boost 
......
ix boost 
..
Unimmunized 4 .....
Unimmunized 1x boost 2x boost
1 Rinalo rolls (12457)
IgM: 2018--
IgGl: 17
I• G n 
,
CR/B220+
(11112)
Isotype+
(3119) 1101-
Ilsotype+Kd'
(2135)
29
g 2a: 271lgG25 71 4 /igG~b 71 4
Ag÷S8Fv "_1gM:28 592-
43
-rIgGl:1 1
12
UA
Figure 4-3: (top) Graphical representation of the immunization schedule used for the
three mice profiled. (bottom) Populations of B cells scored for immunized mice. The
total area of each circle is proportional to the number of cells enumerated with the
phenotypes indicated. Single cells expressing either B220 or IgM on their surfaces
were classified as B cells. The innermost green circle represents the subset of single
secreting B cells for which a complete set of affinity data was obtained. The isotype
distribution for this subset is indicated in the left column. Red circles represent
the subset of single secreting B cells classified as antigen specific (with detectable
dissociation constant, ie. Kd i 100 nM). The isotype distribution in each of these
subsets is shown in the right column. The quality of the microengraved microarrays
can be estimated by comparing the number of single secreting B cells which yielded
a complete set of affinity data to the total number of single secreting B cells detected(ie. relative size of the green circle with respect to the enclosing isotype+ circle).
Here, from left to right, 68.5%, 39% and 20.7%.
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Following a single immunization, the percentage of antigen-specific B cells was
2.5% of the Ig-secreting cells captured in our analysis. This percentage increased to
7.7% for a mouse receiving two immunizations (Figure 4-3). While the frequencies
for antigen-specific cells reported in literature vary with schedules of immunizations,
antigen, and genotype of the animal used, our values are similar to those previously
determined by flow cytometry for actively responding B cells and memory B cells
surface-stained with antigen.
4.4.4 Microengraving detected an increase in class-switched
antibody producing B cells
As expected, the frequency of class-switched antibodies (IgG1) within the collection
of antigen-specific antibodies was higher in the mouse receiving three immunizations
(28%) than the mouse with two (3%). Although isotype switching should not occur in
non specific clones, we have consistently measured a small proportion of IgG1 secreters
in the non-antigen-specific population. These baseline IgG1 levels can be attributable
to antigen specific clones, which show low affinity for antigen and therefore remain
undetectable with our approach. IgG1 clones in the non specific population can also
be due to exposure to other parasitic antigen in the individual mouse considered or
impurities in ova immunization.
4.4.5 Microengraving detected affinity maturation
The median dissociation constant for the antigen-specific antibodies decreased with
the number of immunizations. The majority of the measured affinities, however, were
centered primarily around a relatively narrow range of values (20-30 nM). Only a
small number of cells were producing antibodies with affinities 10 nM (Fig. S2).
This result raises the possibility that B cells producing antibodies with high affini-
ties for an antigen may be present and active before titers of their antibodies are
sufficiently high to detect in sera.
30-
20-
10-
0-
**
**
* *~
t'2
1x boost 2x boost
Figure 4-4: Plot of dissociation constants calculated from individual binding curves
for immunized mice.
4.4.6 Closely related subgroups can be individuated amongst
splenic B cells
To examine further the similarities among the antigen-specific B cells identified in
immunized mice, we applied unsupervised hierarchical clustering (euclidean/average)
to classify the cells on the basis of both the isotype and binding curves for their anti-
bodies (Fig. 3C). For both immunized mice, dendrograms from the cluster analysis,
and the calculated values for Kd, indicated the antigen-specific IgMs were largely
indistinguishable (over the range of concentrations tested) by their binding curves.
One noteworthy exception was observed in the population of cells from the mouse
that received a primary immunization and one secondary challenge. The IgM with
the lowest calculated value of Kd was close to that for the lone antigen-specific IgG1
observed, and both exhibited similar binding curves. The calculated Kd values for
the IgG1 antibodies identified in the mouse immunized three times ranged from 1 nM
to 25 nM, and analysis by clustering classified the cells into five populations based on
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Figure 4-5: Unsupervised hierarchical clustering of antigen-specific cells identified
after one or two boosters. Isotype data was included in the clustering, but set apart
graphically for clarity. The colored branches in the dendrograms indicate cells with
closely related binding curves. The dissociation constants (nM) calculated from a
langmuir curve fit for each clone are listed to the right of the data for each cell.
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shape and intensities of their binding curves.
4.4.7 Conclusions
These results show the appearance and expansion of antigen-specific cells, affinity
maturation, and isotype switching in immunocompetent mice sampled at different
times before and during immunization with chicken ovalbumin, and effectively give a
"snapshot" of the quantities and quality of individual antibody-producing B cells at a
given point in time. It is important to emphasize that not only microengraving-based
profiling of an immune responses is successful in showing the expected pattern of a
general immune response, but also that these observations are done for the first time
at the level of single antibody-secreting splenocytes, a compartment of the humoral
immunity previously inaccessible.
Chapter 5
Discussion
5.1 Conclusions
This work describes the development and application of the microengraving approach
to the high-throughput affinity analysis of antibody repertoires and the multivariate
profiling of in vivo immune responses. The microengraving approach yields quanti-
tative data on the frequencies, specificities, affinities, and isotypes of the antibodies
secreted by primary B cells from immunized mice and also enables direct correlation
of that data to the phenotypes of the cells secreting them.
5.1.1 Microengraving allows routine state based profiling of
immune responses
The use of bioinformatics techniques allows harnessing the multivariate datasets gen-
erated by microengraving for the generation of true "snapshots" of cellular immunity,
capable of describing an humoral immune response by detailing the characteristics
and effects of each immune cell involved. The profiling of a large number of single
cells by microengraving permits us to describe the immune response to an antigen
both at the level of the individual players of immunity and at the level of the overall
response.
Table 5.1: Differential expression of surface biomarkers allows to distinct different B
cell phenotypes and stages in the development of memory B cells. Adapted from [36]
Surface Marker
Antigen
B220
IgD
CD138
Naive B cells Memory B cell Plasma Cells
- ++ ++
++ ++ +
+++ +
_ - ++++
5.1.2 Clusters of B cells can be routinely individuated
B lymphocytes are generally classified in distinct subgroups (eg. germinal center cells,
memory cells, etc.) by means of cell sorting techniques. The expression of determined
surface markers has been associated with distinct in vivo phenotypes and is employed
to map the development stages of memory B cells under a host of different biological
conditions and pathogens exposures.
This work demonstrates how microengraving can be used in analogous manner to
FACS, but with the added advantage of providing data on the antibodies secreted
by each B cell. The ability to collect in a single experiment correlated data on the
surface phenotype and the secreted products of individual lymphocytes allows us to
highlight much finer differences amongst cells with similar expression patterns. Clus-
ters of interrelated (or interdependent) immune cells can be identified by unsupervised
methods, in a manner analogous to the classification of genes into families on the basis
of their microarray expression profiles.
Moreover, differently from FACS analysis or ELISPOT analysis, data generated
by microengraving is multivariate in nature and immediately correlated for each indi-
vidual cell under analysis. Normally, the percentage of cells being part of a group is
determined by means of intersecting boolean categorizations (eg. B220+ and IgD+,
instead of B220+ and IgD-). Microengraving allows us to perform the same cate-
gorization on the basis of surface markers, integrating it with multidimensional in-
formation about the secreted antibodies (or cytokines). Each single cell can thus be
described by a complex multidimensional signature that unequivocally characterizes
it. The ability to obtain such detailed signatures may lead to the development of
finer and more precise biomarkers of B cell development.
5.1.3 Microengraving can be routinely employed in immuno-
logical studies
The simplicity of the microengraving process and the relative inexpensive materials
employed (PDMS chips and fluorescent antibodies) make it possible to perform these
measurement routinely in a laboratory setting, adding to the tools routinely employed
by immunologists in studying immune responses. A single microengraving experiment
requires a very limited sample to be performed, thus allowing parallel analysis of the
samples by means of other techniques.
5.1.4 Advantage over similar methods
The ability to map antibodies to single cells in spatially-defined arrays of microwells
offers an advantage over plaque-based assays that require dilutions of cells over rela-
tively large areas ( 100 cm 2) to ensure spatial isolation. In particular, pEn does not
require assuming clonality by limiting dilution, and does not require analysis of multi-
cellular colonies. In principle, cells of interest can be retrieved by micromanipulation
for genetic analysis[31].
5.1.5 Antibodies secretion at the level of the spleen can be
directly measured
The ability of evaluating B cell secretion allows better evaluation of the interplay
between the cellular immune response to antigens (here limited to primary B cells,
but in principle expandable to every immune cell) and the accompanying humoral
immune response (as determined by serum antibody levels). Our data, for instance,
appears to suggest important differences between the distribution of isotypes in the
antibodies secreted at the level of the spleen and the circulating antibodies following
immunization. Secretion of IgM antibody is abundant even after hyperimmunization,
when the response is expected to shift towards the IgG1 isotype. Considerations re-
garding the half life of the circulating antibodies and their trafficking in and out of
the spleen may play an important role and should be part of future work.
5.1.6 Summary
In summary profiling of immune responses by microengraving makes it is possible
to compare the quality and diversity of a humoral immune response with a level of
resolution not possible with other single assays. It not only provides data equivalent
to both cytometry (phenotype of cells) and immunosorbant assays (isotype, speci-
ficity, and frequency) with one-to-one correlations, but also characteristics not easily
attained by other existing methods with single-cell resolution (ie. affinity).
Routinely available profiles describing the state and evolution of a cellular immune
response should enhance the quality of predictive diagnosis and understanding in the
pathogenesis of diseases, and help determine the efficacy of vaccines.
5.2 Future Directions
This thesis describes the experimental and bioinformatic methods involved in the
development of the microengraving process. Future work will span multiple directions,
ranging from technological development of the process to the profiling of immune
responses to viral pathogens. The following sections outline some suggestions for
further development in some of these areas.
5.2.1 Technological developments
Even though microengraving is a relatively simple experimental procedure, it still
requires some amount of training and suffers from poor automation. Substantial
technological development should be directed toward:
1. the standardization of the microengraving protocol
2. the creation of specific devices and engineering solutions that simplify the cur-
rent process
3. the streamlining of data mining instrumentation and algorithms.
Once more standardized protocols are established and a set of appropriate tools is
developed, the quality and repeatability of the process should improve drastically.
In particular, a) staining of glass slides could be done by means of commercially
available automation, b) chip fabrication could be standardized by the fabrication of
an injection mold and c) the placement of the chip in contact with the glass slide
could be performed by means of an appropriate mechanical device instead of relying
on manual placement. In order to streamline the process of data mining it is necessary
to:
1. improve and customize the chip design
2. develop dedicated instrumentation for imaging and acquisition
3. compile custom software for deployment on computational clusters
New chips should be designed according to the imaging equipment which will be em-
ployed in the analysis: i) Repeating clusters of wells should fit in a single field of view
of the microscope employed, avoiding the necessity of stitching images via software; ii)
More regular spacing between these clusters would aid automated image acquisition,
automated grid alignment by software and database storage; iii) An internal coding
system that contains fiduciary markers and allows the coordinate of each cluster to
be determined without looking at any elements outside the microscope view will also
facilitate downstream software image analysis.
Dedicated instrumentation would reduce the required setup time and the actual
acquisition time currently required to image microwell chips and produced protein
microarrays. Instruments based on spectral imaging are currently able to resolve
up to 11 distinct fluorescent signals and would allow a substantial increase in the
information density of each experiment.
Grid alignment, image analysis, correlation of the multidimensional dataset and
subsequent analysis are currently performed by relatively slow proprietary software
(metamorph and genepix) and custom MATLAB routines (see appendix A). Substan-
tial software development is possible and appears relatively straightforward at this
stage. Hinging on the ongoing development of Cell Profiler (Harvard/MIT Broad
Institute, Anne Carpenter), it should be possible to implement a system capable of
aligning grids, analyze image and create a database of the acquired images in one
single program, capable of running on dedicated computational clusters. These im-
provements should speed up the data mining exponentially, rendering it a matter of
few minutes instead of days. The resulting database would also allow the filtering,
exploration and analysis of the complex multidimensional dataset by the end user.
These efforts should enable the routine collection of data by microengraving,
adding the ability to select relevant antibody producing cells and profile the sta-
tus of humoral immune responses to the panel of techniques at the disposal of the
immunologist.
5.2.2 Cytokine Profiling
The work presented in this thesis is exclusively concerned with antibodies when con-
sidering materials secreted by the cell under analysis. Although antibodies are of
paramount significance in the study of primary B lymphocytes, other secreted prod-
ucts are of interest when profiling the dynamic of immune responses. Cytokines in
particular are responsible for lymphocytes activity and homeostasis, as well as the
regulation of dendritic cells and antigen presenting cells in general.
Cytokine secretion measurements would allow to detect and profile other funda-
mental players of the immune response (such as T lymphocytes and dendritic cells),
while looking at antibodies secretion allows to fully characterize only secreting B lym-
phocytes. Moreover, by measuring secretion of a panel of cytokines and integrating
the data with antibody secretion and surface expression of relevant markers, the di-
mensionality - and thus the sensitivity - of the data collected by microengraving can
increase substantially.
Cytokine secretion measurements will require a) substantial improvements in the
signal-to-noise ratio for the printed protein microarrays currently obtainable by the
process (which should stem in part by a more standardized and streamlined process)
and b) a cheaper source of cytokine-specific capture antibodies.
5.2.3 Immune responses to pathogens
This thesis presents a proof-of-principle study outlining the potential to profile in vivo
immune responses by means of detailed quantitative multidimensional data. However,
this study is limited to the observation of immunity developed following exposure to
a protein antigen. Actual viral or bacterial infections are known to generate more
complex and extensive immune responses in the host. The application of microen-
graving to the monitoring and profiling of such immune responses will be paramount
for further validation of the technology.
Direct comparison with results obtained by FACS and ELISPOT techniques, as
well with observations reported in literature, would allow to further assess the preci-
sion of the technology and may uncover important biological observations previously
unaccessible by these methods. Cytokine/antibodies profiling of responses to differ-
ent classes of pathogens (bacterial or viral, acute or chronic, latent microorganisms,
etc.) will allow to assess the importance of rare populations of immune cells to the
progression and maintenance of infections.
5.2.4 Meta-analysis & Predictive Modeling
Profiles of immune responses based on microengraving data are extremely rich in
information. These profiles, which describe a given immune system in a particular
state with some degree of completeness, can be correlated with other informations.
In principle, in an animal infected by a pathogen, it is possible to link such profiles
at a given time during infection with information relating to the causative pathogen,
the duration, the ultimate course of the infection,etc.
The progressive accumulation of profiles compiled based on microengraving data
would then allow the development of predictive algorithms, capable of determining the
probable outcomes of immune responses (and corresponding infections) on the basis
of a single microengraving measurement. This is analogous to the demonstrated use
of gene microarray in the prognosis of various form of cancer. Obviously, such use
will depend on further validation of the technique, as well as on the accumulation of
a large number of standardized dataset (which in turn would depend on the succesful
creation of a standard format and a public database system).
5.2.5 Antibody repertoires
The work described in this thesis limits its attention to the antibodies directed against
a single antigen. Work directed at mapping in vivo antibody repertoires, by em-
ploying multiple antigens, will lead to profiles of even higher dimensionality. Such
information-dense descriptions of ongoing immune responses will permit more precise
evaluations and differentiation of immune statuses and may grant microengraving
profiling higher diagnostic and predictive power.
Epitope specificity of the secreted antibodies is also not explored in the work pre-
sented here. Microengraving could be employed to map in a high-throughput fashion
the contribution of different epitopes to the immunogenicity of particular antigens.
Similarly, cross-reactivities of produced and circulating antibodies to different strains
and mutation of the same pathogen could be carefully mapped. Data generated in
this fashion may allow to individuate conserved epitopes or factors required for the
propagation and maintenance of infections.
5.2.6 Memory B cells
Lastly, the ability to obtain data on antibody secretion of rare primary B cells, pre-
viously unattainable by other methods, makes microengraving an ideal tool in the
study of memory B cell development. Different stages of memory B cell generation in
the spleen could be mapped with greater precision and correlated to humoral immu-
nity. The secretory dynamic of memory B cells before and after antigen stimulation
could be directly observed, allowing to evaluate the magnitude of recruitment and
new memory generation. It also becomes possible to individuate and enumerate rare
antigen-primed memory B cells without the necessity of antigen stimulation. These
studies have the potential to shed light on important immunological questions, such as
the mechanism of tolerance, the persistence of latent infections and the manifestation
of autoimmune disease.

Appendix A
MATLAB code
A.1 Data acquisition and manipulation
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
%% extract stats from AFF data
suffix = 'agabratio';
%!remember to choose whether we use igpos only or doublepos ova/ig
exps = {'DO W','DOM','DOX',
'D15_W','D15_M', 'D15_X',
'D33.W','D33M', 'D33_X'};
stats = [repmat({'Ratio of Medians (488/532) '},1,3),
repmat({'Ratio of Medians (532/635) '},1,6)];
logs = {'WTdO','MD4dO','XBPdO',
'WTdl5', 'MD4dl5', 'XBPdl5',
'WTd33', 'MD4d33', 'XBPd33'};
for e =l:numel(exps)
%extract data from 5 slides with increasing concentration
datoarray =[];
for conc = 2:6
dato = [];
flagdata = [];
flags = [];
eval(char(strcat('tempslide = ',exps(e),int2str(conc),';')))
dato = tempslide.Data(:,find(strcmp(tempslide.ColumnNames,stats(e))));
flagdata = ...
tempslide.Data(:, find(strcmp(tempslide.ColumnNames, 'Flags')));
if isempty(dato)
warning('did not find the column')
end
dato(-(flagdata == 0),1) = NaN;
datoarray = [datoarray,dato];
end
%save array into properly named variable after initializing it
eval(char(strcat(exps(e),suffix,' = [];')))
eval(char(strcat(exps(e),suffix,' = datoarray;')))
end
A.2 Filtering of data points
A.2.1 Mouse data: Affinity
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
function flaggedaff = flag-affd0_mm(mastruct)
% colors
%dO
% 488 m ova
% 532 - igG & IgM
TI532 = .
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'F532
TI488 = .
mastruct.Data(:,find(strcmp(mastruct.ColumnNames, 'F488
dia = mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
SNR532 = .
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
SNR488 = ...
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
CV532 = ...
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
CV488 = ...
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
sat532 = ...
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
sat488 = ...
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
pxabbg532 = ...
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
pxabbg488 = ...
Total
Total
'Dia.
Intensity'))).;
Intensity')));
')));
'SNR 532')));
'SNR 488')));
'F532 CV')));
'F488 CV')));
'F532 % Sat.'))
'F488 % Sat.'))
'% > B532+2SD')));
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'% > B488+2SD')));
;
;
Smed = ...
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'Sum of Medians (488/532)')));
%% rulesets
% here we do care about saturation.... b/c it skews the ratio towards lower
% values
satthres = 2;
%because of the nature of these signals, both the SNR ratio
%AND the px above bkgrnd
%in these datapts is NOT usable!
%md relaxed
decent = (dia > 50);
TIthres532 = 500000;
covthres = 100;
Smedthres = 1750;
TIthres488 = 120000;
snrthres532 = 5;
pxthres532 = 35;
snrthres488 = 1.5;
pxthres488 = 25;
%md tight
% decent = (dia > 55);
% TIthres532 = 250000;
% covthres = 80;
% Smedthres = 2200;
% TIthres488 = 180000;
% pxthres532 = 55;
% snrthres532 = 5;
% snrthres488 = 2;
% pxthres488 = 30;
igpos = decent & ...
((TI532 > TIthres532) I (SNR532 > snrthres532)) & .
(CV532 < covthres) & (pxabbg532 > pxthres532) & (sat532 < satthres);
%use the sum of the medians before we consider the pt
% we couldn't really put a threshold on the TI or we'll skew the ratios
% towards high values. Sum of the medians would discriminate less.
% However, given the nature of the signal and the crosstalk between stains
% sum of the medians would just pick pts that are high in Ig stain, paradoxically
% skewing the ratio down! Hence...
ovapos = decent & ...
((TI488 > TIthres488) & (SNR488 > snrthres488)) &...
(CV488 < covthres) & (pxabbg488 > pxthres488) & (sat488 < satthres);
%ovapos is not anymore a subset of igpos but a completely separate set,
%which pleases a little mroe my mathematically inclined mind
%the "decent" spots are given by the union of these two sets
%the spots "considered" are the intersection of these two.
%NOTE!! this gives a baseline to the ratios... ie. undetectable OVA is not
%counted.
flaggedaff = mastruct;
flaggedaff.igpos = igpos;
flaggedaff.ovapos = ovapos;
end
A.2.2 Mouse data: Isotype
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
%% ISO ruleset
%%colors are
% 594 - IgM
% 488 - IgG2b
% 532 - IgG2a
% 635 - IgGl
%order of input is
%[IgM, IgGl, IgG2a, IgG2b]
%[594 635 532 488 ]
%for 594 SNR is better than TI in discriminating.
%for other colors is equally valid.
%in terms of CALLS:
% %%%%%%%%%%%xbp%%%%%%%%%%%%%%
% relaxed:
% DOXISO =
% flag-iso.tighter(DOXISO, [150000 150000 200000 220000], [3 1.5 1.5 2],25)
% D15_XISO =
% flagisotighter(Dl5_XISO, [200000 300000 275000 300000], [2.5 2 3 2.5],25)
% D33_XISO =
% flagisotighter(D33_XISO, [150000 200000 200000 220000], [1.5 1 5 1.5],25)
% DOMISO =
% flag-isotighter(D0_MISO, [250000 400000 650000 450000], [1.7 1.5 3 4], 25)
% D15_MISO =
% flagisotighter(D15_MISO, [200000 520000 250000 350000], [2.5 1.5 2 4],25)
% D33-MISO =
% flagisotighter(D33_MISO, [400000 300000 250000 300000], [1.8 1.5 3 5],25)
%
% DOWISO =
% flag-iso.tighter(DOWISO, [270000 450000 600000 375000], [2 2 1.75 1.2],25)
% D15_WISO =
% flag-iso-tighter(D15_WISO, [450000 400000 220000 300000], [2 2 3 4.5],25)
% D33.WISO =
% flag-isotighter(D33_WISO, [250000 300000 275000 275000], [2 1.7 9 3],25)
%% Eli Papa
% filtering out Ig positive spots from 4-color ISO data
% order of input is [IgM, IgG1, IgG2a, IgG2b]
function flaggediso = flagisotighter(mastruct,TIthres,snrthres,pxthres)
TI532 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'F532 Total Intensity')));
TI635 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'F635 Total Intensity')));
TI594 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'F594 Total Intensity')));
TI488 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'F488 Total Intensity')));
dia =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'
SNR532 =
mastruct.Data(:,find(strcmp(mastruct. ColumnNames,
SNR635 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
SNR594 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
SNR488 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,
CV532 =
mastruct.Data(:,
CV635 =
mastruct.Data(:,
CV594 =
mastruct.Data(:,
CV488 =
mastruct.Data(:,
Dia.')));
'SNR
'SNR
'SNR
'SNR
find(strcmp(mastruct.ColumnNames,'F532
find(strcmp(mastruct.ColumnNames,'F635
find(strcmp(mastruct.ColumnNames,'F594
find(strcmp(mastruct.ColumnNames,'F488
532')
635')
594')
488')
CV'))
CV'))
CV'))
CV'))
sat532 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames, 
'F532 % Sat.')));
sat635 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames, 
'F635 % Sat.')));
sat594 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'F594 % Sat.')));
sat488 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'F488 % Sat.')));
pxabbg532 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'% > B532+2SD')));
pxabbg635 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'% > B635+2SD')));
pxabbg594 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'% > B594+2SD')));
pxabbg488 =
mastruct.Data(:,find(strcmp(mastruct.ColumnNames,'% > B488+2SD')));
%we don't care about saturation so much
satthres = 10;
covthres = 100;
decent = (dia > 50);
igGlpos = decent & ...
(SNR635 > SNR594) & (SNR635 > SNR532) & (SNR635 > SNR488) & ...
((TI635 > TIthres(2)) & (SNR635 > snrthres(2))) & .
(CV635 < covthres) & (pxabbg635 > pxthres) & ...
(sat594 < satthres) & (sat532 < satthres) & (sat488 < satthres);
% want to exclude saturation in other channels, b/c usually when there is
% saturation is more than one, dust particles are responsible. on the other
% hand, if just one channel saturates, we'd like to keep the data and
% consider that channel the "winner" (ie. the stronger signal which in turn
% determines the isotype of the spot)
igMpos = decent & ...
(SNR594 > SNR635) & (SNR594 > SNR532) & (SNR594 > SNR488) & ...
((TI594 > TIthres(l)) & (SNR594 > snrthres(l))) & .
(CV594 < covthres) & (pxabbg594 > pxthres) & ...
(sat635 < satthres) & (sat532 < satthres) & (sat488 < satthres);
igG2apos = decent & ...
(SNR532 > SNR635) & (SNR532 > SNR594) & (SNR532 > SNR488) & ...
((TI532 > TIthres(3)) & (SNR532 > snrthres(3))) &...
(CV532 < covthres) & (pxabbg532 > pxthres) &
(sat594 < satthres) & (sat635 < satthres) & (sat488 < satthres);
igG2bpos = decent & ...
(SNR488 > SNR635) & (SNR488 > SNR594) & (SNR488 > SNR532) & ...
((TI488 > TIthres(4)) & (SNR488 > snrthres(4))) &...
(CV488 < covthres) & (pxabbg488 > pxthres) & ...
(sat594 < satthres) & (sat532 < satthres) & (sat635 < satthres);
flaggediso = mastruct;
flaggediso.decent = decent;
flaggediso.igGlpos = igGlpos;
flaggediso.igMpos = igMpos;
flaggediso.igG2apos = igG2apos;
flaggediso.igG2bpos = igG2bpos;
end
A.2.3 Hybridoma data
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
% flagging features in a two color hybridoma expt
function flaggedmastruct = flag-goodspots_3xKb(mastruct,thres)
colSnrG = find(strcmp(mastruct.ColumnNames,'SNR 532'));
colSnrR = find(strcmp(mastruct.ColumnNames,'SNR 635'));
colCVG = find(strcmp(mastruct.ColumnNames,'F532 CV'));
colCVR = find(strcmp(mastruct.ColumnNames,'F635 CV'));
colGsat = find(strcmp(mastruct.ColumnNames,'F532 % Sat.'));
colRsat = find(strcmp(mastruct.ColumnNames,'F635 % Sat.'));
colSmed = find(strcmp(mastruct.ColumnNames,'Sum of Medians (532/635)'));
colpxabbgG = find(strcmp(mastruct.ColumnNames,'% > B532+2SD'));
colpxabbgR = find(strcmp(mastruct.ColumnNames,'% > B635+2SD'));
SnrG = mastruct.Data(:,colSnrG);
SnrR = mastruct.Data(:,colSnrR);
CVG = mastruct.Data(:,colCVG);
CVR = mastruct.Data(:,colCVR);
Gsat = mastruct.Data(:,colGsat);
Rsat = mastruct.Data(:,colRsat);
Smed = mastruct.Data(:,colSmed);
pxabbgG = mastruct.Data(:,colpxabbgG);
pxabbgR = mastruct.Data(:,colpxabbgR);
decentspots = (CVG < 100) & (CVR < 100) & (Gsat < 2) & (Rsat < 2);
maxSmed = max(Smed(decentspots)); %trying to exclude saturated pixel
%%%%%%%%%%%%%%%
%autothres = 0.018*maxSmed; %get output, just to check
%thres - 650 for ipM; 850 for 500nM
%just set it in advance for everyone:
goodspots = decentspots & (Smed > thres);
Igpos = (pxabbgR > 50) ((pxabbgR > 20) & (SnrR > 1.5));
%px above bg R: in kblpm 50 seems a good value,
% 20 is just for extreme cases,
% but does not do much;
% use it just bc we have cell data
%Snr R: could be more restrictive, but you get some good spots for 1.5
%NB - spots that are green but not red may be due to some strange occurence
%in the expt, but they should be ruled out by the constraints on the Ig
%NB - we decided to keep spots that seems to have no Ag signal. This may
%increase the noise, but makes sure we are detecting very low conc of Ag.
%If the cell continues to not bind any antigen, it will be excluded anyway
%when we align all affinities (or it be clustered together)
%save what's done
flaggedmastruct = mastruct;
flaggedmastruct.goodspots = goodspots;
flaggedmastruct.Ig-pos = Ig-pos;
% and bring everything together
flaggedmastruct.goodratios = goodspots & Igpos;
%this still needs to pass through cell counts masks
end
A.2.4 Cells
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
%% from cell logs, extract secreters, single cells, etc.
function logstruct = classifywells(logarray)
logstruct.source = logarray;
logstruct.populatedwell = (logarray(:,4) 2 1);
logstruct.singleb220 = ...
(logarray(:,5) == 1) & (logarray(:,6) == 0) & (logarray(:,7) == 0);
logstruct.singleantibcr =
(logarray(:,5) == 0) & (logarray(:,6) == 1) & (logarray(:,7) == 0);
logstruct.singledoublest = ...
(logarray(:,5) == 0) & (logarray(:,6) == 0) & (logarray(:,7) == 1);
logstruct.singlebcell = ...
logstruct.singleb220 I
logstruct.singleantibcr
logstruct.singledoublest;
logstruct.singlenonsecreter = (logarray(:,4) == 1) &
(logarray(:,5) == 0) & (logarray(:,6) == 0) & (logarray(:,7) == 0);
logstruct.singlecell = ...
logstruct.singlenonsecreter logstruct.singlebcell;
end
% example call
%%%%%%%%%%%%%%%%%
% logs = whos('*log');
%
% for k = 1:numel(logs)
% eval([logs(k).name,
% end
%call from structs
% logs = whos('*log');
% for k = 1:numel(logs)
% eval([logs(k).name,
% end
= classifywells(',logs(k).name ,');'])
= classifywells(',logs(k).name ,'.source);'])
A.3 Visualization
A.3.1 Create affinity maps visualizations
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
function affmap(data,varargin)
figure
pcolor(padarray(data,[1 1],0,'post'))
shading flat
colormap(french(256,2))
set(gca,'Clim',[-1 1], 'XTick',[1.5:1:5.5],'XTickLabel',
{'10pM','100pM', 'l nM','10nM','100nM'})
if -isempty(varargin) && varargin{1} ==1
set(gca,'YTick', [1.5:1:size(data,1) +1],'YTickLabel',
[1:1:size(data,1)])
if -isempty(varargin{2})
set(gca,'YTickLabel',varargin{2})
end
else
axis off
end
end
A.3.2 Associate information with affinity maps visualiza-
tions
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
% isolate subset and calculate things needed to make a pretty heatmap
%eg call
% d3310nmap =
% makelabeledsubsetmaps(D33.Wagabratio, (D33W-idh_10nmbndr & -isnan(D33-WISOs)));
function mapstruct = ...
makelabeledsubsetmaps(concs,affdata,isodata,isonumdata,iddata,mask)
%save basis of data
mapstruct.mask = mask;
mapstruct.aff = affdata(mask,:);
%row normalize! and center too..
for r=l:size(mapstruct.aff,1)
mapstruct.normaff(r,:) =
mapstruct.aff(r,:) + min(mapstruct.aff(r,:));
mapstruct.normaff(r,:) = ...
mapstruct.normaff(r,:) / max(mapstruct.normaff(r,:));
mapstruct.normcenteraff(r,:) = ...
mapstruct.normaff(r,:) 
- median(mapstruct.normaff(r,:));
end
%calculate and save Kd's
mapstruct.Kd = fitBindK(concs,mapstruct.normaff);
%save other stuff
mapstruct.iso = isodata(mapstruct.mask);
mapstruct.isonum = isonumdata(mapstruct.mask);
mapstruct.ids = iddata(mapstruct.mask);
%sort based on isotype and save reordering
[mapstruct.sorted mapstruct.sortindex] = ...
sortrows([mapstruct.isonum,mapstruct.aff]);
mapstruct.affsorted = mapstruct.sorted(:,2:end);
mapstruct.isonumsorted = mapstruct.sorted(:,l);
clear mapstruct.sorted
%sorter the other stuff
mapstruct.isosorted = mapstruct.iso(mapstruct.sortindex);
mapstruct.Kdsorted = mapstruct.Kd(mapstruct.sortindex);
mapstruct.normaffsorted = mapstruct.normaff(mapstruct.sortindex,:);
mapstruct.normcenteraffsorted = ...
mapstruct.normcenteraff(mapstruct.sortindex,:);
mapstruct.idsorted = mapstruct.ids(mapstruct.sortindex);
%adjust isotype "colors"
mapstruct.isonumsorted(mapstruct.isonumsorted 
== 1) = -0.5;
mapstruct.isonumsorted(mapstruct.isonumsorted 
== 2) = 0.5;
%plot reference maps
affmap(mapstruct.normcenteraffsorted,1,mapstruct.isosorted)
affmap(mapstruct.normcenteraffsorted,1,mapstruct.Kdsorted)
title(['median Kd (norm): ', num2str(median(mapstruct.Kdsorted))])
affmap(mapstruct.normcenteraffsorted,1,mapstruct.idsorted)
end
function Kest = fitBindK(concs, ratiodata)
langmuir = @(k,xdata) (xdata)./(k + xdata);
Kest = [];
for row = 1:size(ratiodata,l)
ydata = ratiodata(row,:);
if any(isnan(ydata))
warning('missing data pt')
end
k = isqcurvefit(langmuir,rand(l),concs,ydata);
Kest = [Kest; k];
end
end
A.3.3 Color Mapping
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
function h = french(m,flag)
%FRENCH French's flag color map.
if nargin < 1
m = size(get(gcf,'colormap'),l);
else
if isempty(m)
m = size(get(gcf,'colormap'),l);
end
end
if nargin < 2, flag = 1; end
nl = fix(3*m/8);
n2 = fix(m/4);
n3 = fix(m/2);
switch flag
case 1
r =
b =
case 2
r =
b =
[ones(nl+n2,1)
[ (0:nl-1) '/nl;
[(0:nl-1)'/nl;
; (n1-1:-1:0) '/nl;];
ones(n2,1); (nl-l:-i
ones (nl+n2, 1) ; ] ;
)' I];
(sqrt(1-((1:n3)/n3).^2))'];
ones(n3,1)];
:0) '/nl;];
end
h = [r g b];
if size(h,l) < m
h(ceil(m/2)+1:m,:) = h(ceil(m/2):end,:);
h(ceil(m/2),:) = 1;
end
A.4 Compare clustering methods to assess quality
of distance/linkage combinations
A.4.1 Hierarchical
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
function [coeffcell,trees, = compareclustermethod(data)
coeffcell = {};
distancemethod = {
'euclidean';
'seuclidean';
% 'mahalanobis';
'cityblock';
% 'minkowski';
% 'cosine';
% 'correlation';
'spearman';
% 'hamming';
% 'jaccard';
'chebychev';
linkmethod = {
% 'single';
'complete';
'average';
'weighted';
'median';
dists]
[ones(n3,1) ; (sqrt(l-((1:n3)/n3).^2)
[flipud( (sqrt(1-((l:n3)/n3) .^2))');
[flipud((sqrt(l1-((1:n3)/n3).^2))');
% 'centroid';
'ward';
};
trees = cell(numel(distancemethod),numel(linkmethod));
dists = cell(numel(distancemethod),2);
coeffcell = cell(numel(distancemethod),numel(linkmethod));
%find distances and store them in a table with a descriptor
for j = l:numel(distancemethod)
dists{j,2} = pdist(data,distancemethod{j});
dists(j,l) = {distancemethod{j}};
end
%perform linkage to form trees and evaluate the cophenet coeff as
%determinant of quality
for 1 = l:numel(linkmethod)
for d = l:numel(distancemethod)
% if (strcmp(linkmethod{l},'ward') I
% strcmp(linkmethod{l}, 'median')) &
% (-strcmp(distancemethod{d}, 'euclidean'))
% continue %these linkages fcns need euclidean distance input
% end
trees{d,l} = linkage(dists{d,2},linkmethod{l});
coeffcell{d,l} = cophenet(trees{d,l},dists{d,2});
end
end
%fill in the rows and columns of the coeff'and trees matrix
trees = [distancemethod, trees];
coeffcell = [distancemethod, coeffcell];
trees = [{'DIST\LINK'},linkmethod'; trees];
coeffcell = [{'DIST\LINK'},linkmethod';coeffcell];
% %example call
% exps = {'DO_W','DOMI','DOX',' 5W','D15W','D ','D15X','D33_W','D33_M','D33_X'};
% for e = 1:numel(exps)
% eval(char(strcat('[',exps(e),'coph , ',exps(e), 'trees , ',exps(e),'dist]
%= compareclustermethods ( ',exps(e),'agabratio);')))
% end
% set(0,'RecursionLimit',3000)
% figure
% plt = 1;
% for i = 1:7
% for j = 1:5
% subplot (7, 5,plt);
% plt = plt+l;
% if isempty(trees{i,j))
% continue
% end
% dendrogram(trees{i,j}, 'colorthreshold','default');
% set(gca,'TickDir','out','TickLength', [.002 0],'XTickLabel', []);
% end
% end
Dendrograms
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
set(0,'RecursionLimit',3000)
figure
plt = 1;
for i = 1:7
for j = 1:5
subplot(7,5,plt);
plt = plt+l;
if isempty(trees{i,j})
continue
end
dendrogram(trees{i,j}, 'colorthreshold', 'default');
set(gca,'TickDir','out','TickLength',[.002 0],'XTickLabel',[]);
end
end
A.4.2 K-means
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
distmeth = {'cityblock','sqEuclidean','correlation'};
for meth = l:numel(distmeth)
for numclust = 2:6
[temp,tempmeans] = kmeans(allratiodatasinglegood,numclust, 
'dist',...
distmeth{meth}, 'display','final', 'replicates',5);
eval([ 'idx',int2str(numclust),'_',distmeth{meth}, 
' = temp;']);
eval([ 'idx',int2str(numclust),'mean_',distmeth{meth}, 
' = temp;']);
% figure
% [tempsilh,h] = silhouette(allratiodata-singlegood,temp,distmeth{meth});
% title( [distmeth{meth},' ',int2str(numclust)]);
eval(['silh',int2str(numclust),'_',distmeth{meth},' = tempsilh;']);
end
end
A.5 Extract frequency statistics
% Eliseo Papa
% Harvard/MIT Health Science & Tech. Inst
logs = {'WTdO','MD4dO','XBPdO',
'WTdl5','MD4dl5', 'XBPdl5',
'WTd33', 'MD4d33', 'XBPd33'};
exps = ('DO.W','DO0M','DOX',
'D15_W','D15_M','D15_X',
'D33_W','D33M', 'D33_X'};
for grid = l:numel(exps)
jointigpos = [];
jointovapos = [];
jointbothpos = [];
for concs = 2:6
eval(char(strcat('tempslide = ',exps(grid),int2str(concs),';')))
jointigpos = [jointigpos, tempslide.igpos];
jointovapos = [jointovapos, tempslide.ovapos];
jointbothpos = [jointbothpos, (tempslide.ovapos & tempslide.igpos)];
end
eval(char(strcat('gridcelllog = ',logs(grid),'_celllog;')))
%compare ig+ trough slides with cellcounts
igpositives.foraff = (sum(jointbothpos,2) 2 3);
truthtable = [ sum(grid-celllog.singlecell & igpositives_foraff),
sum(-gridcelllog.singlecell & igpositivesforaff);
sum(grid-celllog.singlecell & -igpositives.foraff),
sum(-gridcelllog.singlecell & -igpositivesforaff)];
b220truthtable = [ sum(gridcelllog.singleb220 & igpositivesforaff),
sum(-gridcelllog.singleb220 & igpositives_foraff);
sum(grid-celllog.singleb220 & -igpositives-foraff),
sum(-gridcelllog.singleb220 & -igpositives_foraff)];
antiBCRtruthtable = [ sum(grid.celllog.singleantibcr & igpositives.foraff),
sum(-gridcelllog.singleantibcr & igpositivesforaff);
sum(gridcelllog.singleantibcr & -igpositivesforaff),
sum(-grid.celllog.singleantibcr & -igpositives.foraff)];
eval(char(strcat(exps(grid), 'ttable = truthtable;')))
eval(char(strcat(exps(grid),'_ttable = b220truthtable;')))
eval(char(strcat(exps (grid), '_antiBCRttable = antiBCRtruthtable;')))
end
A.6 Binding curve fit
function estimates = fitbindingcurve(xdata,ydata)
% Call fminsearch with a random starting point.
startpoint = rand(1, 3);
model = @bindingcurve;
options.MaxFunEvals = le7;
estimates = fminsearch(model, start.point, options);
function sse = bindingcurve(params)
Kd = params(1);
max = params(2);
min = params(3);
FittedCurve = min + max*(xdata ./ (Kd + xdata));
ErrorVector = FittedCurve 
- ydata;
sse = sum(ErrorVector .^ 2);
end
end
Bibliography
[1] Global atlas of infectious diseases: an interactive information and mapping sys-
tem. World Health Organization.
[2] Rafi Ahmed, Michael B A Oldstone, and Peter Palese. Protective immunity and
susceptibility to infectious diseases: lessons from the 1918 influenza pandemic.
Nat Immunol, 8(11):1188-93, Nov 2007.
[3] D Barouch, N Letvin, and R Seder. The role of cytokine dnas as vaccine adjuvants
for optimizing cellular immune responses. Immunological Reviews, Jan 2004.
[4] Nadia L Bernasconi, Elisabetta Traggiai, and Antonio Lanzavecchia. Mainte-
nance of serological memory by polyclonal activation of human memory b cells.
298(5601):2199-202, Dec 2002.
[5] Timothy J Bradford, Xiaoju Wang, and Arul M Chinnaiyan. Cancer immu-
nomics: using autoantibody signatures in the early detection of prostate cancer.
Urol Oncol, 24(3):237-42, Jan 2006.
[6] Ulisses M Braga-Neto and Ernesto T A Marques. From functional genomics
to functional immunomics: new challenges, old problems, big rewards. PLoS
Comput Biol, 2(7):e81, Jul 2006.
[7] Atul Butte. The use and analysis of microarray data. Nature reviews Drug
discovery, 1(12):951-60, Dec 2002.
[8] Atul J. Butte, Pablo Tamayo, Donna Slonim, Todd R. Golub, and Isaac S.
Kohane. Discovering functional relationships between rna expression and
chemotherapeutic susceptibility using relevance networks. Proc Natl Acad Sci
USA, 97(22):12182, Oct 2000.
[9] Michel Caron, Genevieve Choquet-Kastylevsky, and Raymonde Joubert-Caron.
Cancer immunomics using autoantibody signatures for biomarker discovery. Mol
Cell Proteomics, 6(7):1115-22, Jul 2007.
[10] A Casadevall, M Feldmesser, and L Pirofski. Induced humoral immunity and
vaccination against major human fungal pathogens. Current Opinion in Micro-
biology, Jan 2002.
[11] Rodrigo F Chuaqui, Robert F Bonner, Carolyn J M Best, John W Gille-
spie, Michael J Flaig, Stephen M Hewitt, John L Phillips, David B Krizman,
Michael A Tangrea, Mamoun Ahram, W Marston Linehan, Vladimir Knezevic,
and Michael R Emmert-Buck. Post-analysis follow-up and validation of microar-
ray experiments. Nat Genet, 32 Suppl:509-14, Dec 2002.
[12] Irun R Cohen. Real and artificial immune systems: computing the state of the
body. Nat Rev Immunol, 7(7):569-74, Jul 2007.
[13] C C Czerkinsky, L A Nilsson, H Nygren, O Ouchterlony, and A Tarkowski. A
solid-phase enzyme-linked immunospot (elispot) assay for enumeration of specific
antibody-secreting cells. J Immunol Methods, 65(1-2):109-21, Dec 1983.
[14] C C Czerkinsky, A Tarkowski, L A Nilsson, O Ouchterlony, H Nygren, and
C Gretzer. Reverse enzyme-linked immunospot assay (relispot) for the detection
of cells secreting immunoreactive substances. J Immunol Methods, 72(2):489-96,
Sep 1984.
[15] Susmita Datta and Somnath Datta. Comparisons and validation of statisti-
cal clustering techniques for microarray gene expression data. Bioinformatics,
19(4):459-66, Mar 2003.
[16] Thomas Dorner and Andreas Radbruch. Antibodies and b cell memory in viral
immunity. Immunity, 27(3):384-92, Sep 2007.
[17] J Foote and H N Eisen. Kinetic and affinity limits on antibodies produced during
immune responses. Proc Natl Acad Sci USA, 92(5):1254-6, Feb 1995.
[18] L Hangartner, R Zinkernagel, and H Hengartner.... Antiviral antibody re-
sponses: the two extremes of a wide spectrum. Nat. Rev. Immunol, Jan 2006.
[19] Julie Hardouin, Jean-Paul Lasserre, Loik Sylvius, Raymonde Joubert-Caron,
and Michel Caron. Cancer immunomics: from serological proteome analysis
to multiple affinity protein profiling. Ann N Y Acad Sci, 1107:223-30, Jun 2007.
[20] K Hayakawa, R Ishii, K Yamasaki, T Kishimoto, and R R Hardy. Isolation of
high-affinity memory b cells: phycoerythrin as a probe for antigen-binding cells.
Proc Natl Acad Sci USA, 84(5):1379-83, Mar 1987.
[21] P Hegde, R Qi, K Abernathy, C Gay, S Dharap, R Gaspard, J E Hughes, E Snes-
rud, N Lee, and J Quackenbush. A concise guide to cdna microarray analysis.
BioTechniques, 29(3):548-50, 552-4, 556 passim, Sep 2000.
[22] Charles Janeway, Kenneth P Murphy, Paul Travers, and Mark Walport.
Janeway's immunobiology. Garland Science, New York, NY, 7th ed. edition,
2008.
[23] N Jerne and A Nordin. Plaque formation in agar by single antibody-producing
cells. Science, 140(3565):405, Apr 1963.
[24] S M Kaech and R Ahmed. Memory cd8+ t cell differentiation: initial anti-
gen encounter triggers a developmental program in naive cells. Nat Immunol,
2(5):415-22, May 2001.
[25] G Kelsoe. Cloning of mitogen- and antigen-reactive b lymphocytes on filter paper
discs. i. a description of the technique and of methods for the analysis of colonies.
J Immunol Methods, 76(2):345-63, Feb 1985.
[26] G Kelsoe. Cloning of mitogen- and antigen-reactive b lymphocytes on filter
paper disks: phenotypic and genotypic analysis of b cell colonies. Meth Enzymol,
150:287-304, Jan 1987.
[27] G Kelsoe and J T Stout. Cloning of mitogen- and antigen-reactive b lympho-
cytes on filter paper discs. ii. paratope frequencies within the mitogen-selected
repertoire. Cell Immunol, 98(2):506-16, Apr 1986.
[28] N R Klinman and G Aschinazi. The stimulation of splenic foci in vitro. J
Immunol, 106(5):1338-44, May 1971.
[29] Antonio Lanzavecchia, Nadia Bernasconi, Elisabetta Traggiai, Claudia R
Ruprecht, Davide Corti, and Federica Sallusto. Understanding and making use
of human memory b cells. Immunol Rev, 211:303-9, Jun 2006.
[30] Yuk Fai Leung and Duccio Cavalieri. Fundamentals of cdna microarray data
analysis. Trends Genet, 19(11):649-59, Nov 2003.
[31] J Christopher Love, Jehnna L Ronan, Gijsbert M Grotenbreg, Annemarthe G
van der Veen, and Hidde L Ploegh. A microengraving method for rapid selection
of single cells producing antigen-specific antibodies. Nat Biotechnol, 24(6):703-7,
Jun 2006.
[32] B Maecker, von Bergwelt-Baildon, K S Anderson, R H Vonderheide, and
J L Schultze. Linking genomics to immunotherapy by reverse immunology-
'immunomics' in the new millennium. Curr Mol Med, 1(5):609-19, Nov 2001.
[33] Vinay S Mahajan, Ilya B Leskov, and Jian Zhu Chen. Homeostasis of t cell
diversity. Cell Mol Immunol, 2(1):1-10, Feb 2005.
[34] M Juanita Martinez, Anthony D Aragon, Angelina L Rodriguez, Jose M We-
ber, Jerilyn A Timlin, Michael B Sinclair, David M Haaland, and Margaret
Werner-Washburne. Identification and removal of contaminating fluorescence
from commercial and in-house printed dna microarrays. Nucleic Acids Research,
31(4):e18, Feb 2003.
[35] M Maruyama, K P Lam, and K Rajewsky. Memory b-cell persistence is inde-
pendent of persisting immunizing antigen. Nature, 407(6804):636-42, Oct 2000.
[36] Louise J McHeyzer-Williams and Michael G McHeyzer-Williams. Antigen-
specific memory b cell development. Annu Rev Immunol, 23:487-513, Jan 2005.
[37] M G McHeyzer-Williams, M J McLean, G J Nossal, and P A Lalor. The dynamics
of t cell-dependent b cell responses in vivo. Immunol Cell Biol, 70 ( Pt 2):119-27,
Apr 1992.
[38] Amy S McKee, Michael W Munks, and Philippa Marrack. How do adju-
vants work? important considerations for new generation adjuvants. Immunity,
27(5):687-90, Nov 2007.
[39] R Nayak, S Mitra-Kaushik, and M S Shaila. Perpetuation of immunological
memory: a relay hypothesis. Immunology, 102(4):387-95, Apr 2001.
[40] J Quackenbush. Computational analysis of microarray data. Nat Rev Genet,
2(6):418-27, Jun 2001.
[41] John Quackenbush. Microarray data normalization and transformation. Nat
Genet, 32 Suppl:496-501, Dec 2002.
[42] Francisco J Quintana, Gad Getz, Guy Hed, Eytan Domany, and Irun R Cohen.
Cluster analysis of human autoantibody reactivities in health and in type 1 dia-
betes mellitus: a bio-informatic approach to immune complexity. J Autoimmun,
21(1):65-75, Aug 2003.
[43] Francisco J Quintana, Peter H Hagedorn, Gad Elizur, Yifat Merbl, Eytan Do-
many, and Irun R Cohen. Functional immunomics: microarray analysis of igg
autoantibody repertoires predicts the future response of mice to induced dia-
betes. Proc Natl Acad Sci USA, 101 Suppl 2:14615-21, Oct 2004.
[44] Rino Rappuoli. Bridging the knowledge gaps in vaccine design. Nat Biotechnol,
25(12):1361-6, Dec 2007.
[45] M Regner and P Lambert. Autoimmunity through infection or immunization?
Nature Immunology, Jan 2001.
[46] J W Rohrer, K Vasa, and R G Lynch. Myeloma cell immunoglobulin expression
during in vivo growth in diffusion chambers: evidence for repetitive cycles of
differentiation. J Immunol, 119(3):861-6, Sep 1977.
[47] Victor C Rucker, Karen L Havenstrite, and Amy E Herr. Antibody microarrays
for native toxin detection. Anal Biochem, 339(2):262-70, Apr 2005.
[48] R A Schultz, T Nielsen, J R Zavaleta, R Ruch, R Wyatt, and H R Garner.
Hyperspectral imaging: a novel approach for microscopic analysis. Cytometry,
43(4):239-47, Apr 2001.
[49] R Seder and A Hill. Vaccines against intracellular infections requiring cellular
immunity. Nature, Jan 2000.
[50] Michael B Sinclair, Jerilyn A Timlin, David M Haaland, and Margaret Werner-
Washburne. Design, construction, characterization, and application of a hyper-
spectral microarray scanner. Applied optics, 43(10):2079-88, Apr 2004.
[51] Seng-Lai Tan, Gopinath Ganji, Bryan Paeper, Sean Proll, and Michael G Katze.
Systems biology and the host response to viral infection. Nat Biotechnol,
25(12):1383-9, Dec 2007.
[52] Andreas Wack and Rino Rappuoli. Vaccinology at the beginning of the 21st
century. Curr Opin Immunol, 17(4):411-8, Aug 2005.
[53] Nan-Ping Weng, Kebin Liu, Marta Catalfamo, Yu Li, and Pierre A Henkart.
I1-15 is a growth factor and an activator of cd8 memory t cells. Ann N Y Acad
Sci, 975:46-56, Dec 2002.
[54] E John Wherry, Daniel L Barber, Susan M Kaech, Joseph N Blattman, and Rafi
Ahmed. Antigen-independent memory cd8 t cells do not develop during chronic
viral infection. Proc Natl Acad Sci USA, 101(45):16004-9, Nov 2004.
[55] G M Whitesides, E Ostuni, S Takayama, X Jiang, and D E Ingber. Soft lithog-
raphy in biology and biochemistry. Annual review of biomedical engineering,
3:335-73, Jan 2001.
[56] D Wraith, M Goldman, and P Lambert. Vaccination and autoimmune disease:
what is the evidence? The Lancet, Jan 2003.
[57] R M Zinkernagel, M F Bachmann, T M Kiindig, S Oehen, H Pirchet, and H Hen-
gartner. On immunological memory. Annual Review of Immunology, 14:333-67,
Jan 1996.
